Introduce Trilaciclib in Periph Vein, Perc, New Tech 7

This code describes the administration of Trilaciclib, a novel chemoprotective agent, directly into a vein located in the periphery of the body. The procedure is performed through the skin, without requiring a surgical incision. This medication is designed to protect bone marrow from damage caused by certain chemotherapy regimens.

This code is used when Trilaciclib is given intravenously to patients undergoing chemotherapy, typically for small cell lung cancer, to mitigate chemotherapy-induced myelosuppression. It specifically applies to the initial or subsequent infusions of this drug via a peripheral IV line.

• Ensure documentation specifies "Trilaciclib" and not a generic chemoprotective agent.